Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
暂无分享，去创建一个
A. Rosenwald | M. Ziepert | W. Klapper | N. Schmitz | D. Scott | G. Ott | G. Lenz | H. Stein | D. Lenze | M. Pfreundschuh | A. Feller | M. Hummel | T. Barth | H. Bernd | S. Cogliatti | M. Hansmann | P. Möller | M. Szczepanowski | L. Trümper | M. Löffler | H. Horn | A. Staiger | S. Hartmann